Related Experiment Video
Updated: Jul 10, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
[Contribution of statistical analytic tools to risk assessment]
1Responsable de l'unité de veille toxicologique et de l'évaluation non--clinique, Agence française de sécurité sanitaire des produits de santé (Afssaps), 143-145 boulevard Anatole France, F 93285 Saint-Denis Cedex.
Abstract:
Risk assessment is an important aspect of health safety. The main basis of information comes from the identification of adverse effects observed in animal studies, in vitro models, or in silico computer models. These data are used to construct a proof scaffold with an inherent double uncertainty about its clinical pertinence and the probability of occurrence in man. This uncertainty can be reduced with statistical analytical tools, particularly factorial analysis and principal component analysis. Factorial analysis describes a group of variables using a linear combination of underlying common factors associated with a single variable summarizing the specific contribution of each initial variable, thus providing evidence demonstrating the probability of the undesirable effect under consideration. Principal component analysis consists in expressing a group of variables (undesirable effects) by linear combinations of uncorrelated factors. These factors account for a more or less extensive proportion of the data variability thus limiting loss of data pertinence.
Related Concept Videos
Statgraphics
Statistical Methods for Analyzing Epidemiological Data
Steps in Outbreak Investigation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Statistical Software for Data Analysis and Clinical Trials
Statistical Analysis System (SAS)
Applications: SAS finds applications in numerous fields, including healthcare for clinical trial analysis, finance for risk assessment, marketing for customer data analysis, and...